MEDISO
ActiveThe computed 12-month bankruptcy probability of MEDISO is 2.1% (moderate). The 2025 annual accounts show equity of €1k and a net result of €117k. Equity is growing by ~7% per year across the filed fiscal years. The company has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
73
/ 100
Healthy▼ -27 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency11▼-89
Growth32▼-20
Stability100
Bankruptcy probability, 12 months
2.1%
Moderate
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity tight (current ratio 1.0 against 10.81 in 2024), and 99.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
0.2%
Return on assets
27%
Age of the figures
8 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-05-2026, 64 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
64 d early
2024
44 d early
2023
19 d early
2022
54 d early
2021
31 d late
2020
30 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
13-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€1k▼ 99.7%
2024 · €306k
2020: €143k
2021: €212k
2022: €305k
2023: €243k
2024: €306k
2020 → 2025
Total assets
€431k▲ 27.8%
2024 · €337k
2020: €220k
2021: €235k
2022: €356k
2023: €284k
2024: €337k
2020 → 2025
Net result
€117k▲ 5.5%
2024 · €111k
2020: €142k
2021: €69k
2022: €93k
2023: €102k
2024: €111k
2020 → 2025
Working capital
€276▼ 99.9%
2024 · €305k
2020: €123k
2021: €202k
2022: €302k
2023: €241k
2024: €305k
2020 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€212k-€305k▲ 43.7%€243k▼ 20.3%€306k▲ 26.2%€1k▼ 99.7%
Operating result€87k-€120k▲ 37.3%€132k▲ 9.8%€146k▲ 11.1%€156k▲ 6.9%
Net result€69k-€93k▲ 34.8%€102k▲ 9.7%€111k▲ 7.9%€117k▲ 5.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2025 is 7% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €431k
Fixed assets
€724▼ 54.9%
Current assets
€430k▲ 28.2%
Equity and liabilities €431k
Equity
€1k▼ 99.7%
Debt
€430k▲ 1,286%
The debt ratio rises from 9.2% to 99.8%: debt grows while equity shrinks.
Key figures and ratios
EBITDA
€157k▲
2024 · €147k
Cash flow
€117k▲
2024 · €112k
Solvency
0.2%▼
2024 · 90.8%
Current ratio
1.00▼
2024 · 10.81
Quick ratio
1.00▼
2024 · 10.81
ROA
27.0%▼
2024 · 32.8%
Interest coverage
493.81▼
2024 · 765.88
Debt
€430k▲
2024 · €31k
Debt ≤ 1 year
€430k▲
2024 · €31k
Income taxes
€39k▲
2024 · €35k
A ratio outside any meaningful range has been withheld (balance sheet total €431k, equity €1k).
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€337k€431k▲
Fixed assets21/28€2k€724▼
Tangible fixed assets22/27€2k€724▼
Furniture and vehicles24€2k€724▼
Other tangible fixed assets26€0-
Current assets29/58€336k€430k▲
Amounts receivable within one year40/41€54k€92k▲
Trade receivables40€54k€64k▲
Other amounts receivable41-€28k
Cash at bank and in hand54/58€281k€328k▲
Deferred charges and accrued income490/1€408€10k▲
Equity and liabilities
Total equity and liabilities10/49€337k€431k▲
Equity10/15€306k€1k▼
Contributions10/11€1k€1k=
Profit (loss) carried forward14€305k€0▼
Amounts payable17/49€31k€430k▲
Amounts payable within one year42/48€31k€430k▲
Trade debts44€2k€1k▼
Suppliers440/4€2k€1k▼
Taxes, remuneration and social security45€25k€70k▲
Taxes450/3€25k€70k▲
Other amounts payable47/48€4k€358k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1k€882▼
Other operating charges640/8€2k€2k▲
Gross operating margin9900€149k€159k▲
Operating profit (loss)9901€146k€156k▲
Financial income75/76B€0€0▼
Recurring financial income75€0€0▼
Financial charges65/66B€192€318▲
Recurring financial charges65€192€318▲
Profit (loss) for the period before taxes9903€146k€156k▲
Income taxes67/77€35k€39k▲
Profit (loss) for the period9904€111k€117k▲
Profit (loss) for the period to be appropriated9905€111k€117k▲
Appropriation of the result
Profit (loss) to be appropriated9906€352k€422k▲
Profit (loss) brought forward from the previous period14P€242k€305k▲
Profit to be distributed694/7€47k€422k▲
Return on contributions (dividend)694€47k€422k▲
The notes to these accounts (15 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-05
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
17-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
12-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
07-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-12
Financial
Weakest financial yearnet €69k ▼51.4%
Net result drops to €69k, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity quadruplescurrent ratio 9.80
Current ratio from 2.59 to 9.80; short-term debt falls from €78k to €23k.
31-12
Financial
Equity above €200kEq €212k ▲48.6%
2 profitable years in a row build equity to €212k.
01-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Pieters-Leeuw · 1 establishment unit since 2019
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Zuunkouter 61600 Sint-Pieters-LeeuwGround area
234 m²
Building footprint
80 m²
Parcel 23582E0266/00W009, Flanders. Linked by address, not a title deed.
1 establishment unit
MEDISO
since 20192.303.966.962
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23582E0266/00W009 | Flanders | 234 m² | 1 · 80 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded30-07-2019
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Data from official sources, last processed on 13-09-2026. Scores and ratios are computed by Checked and are not a credit decision.